<DOC>
	<DOC>NCT01368419</DOC>
	<brief_summary>This study is to explore the clinical efficacy of continuous Endostar infusion combined with radiotherapy in esophageal cancer patients.</brief_summary>
	<brief_title>Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Histological or cytological diagnosis of previously untreated stage IIII esophageal cancer Measurable disease according to RECIST criteria ECOG Performance Status 01 The length of esophageal carcinoma ≤ 10 cm Hematologic function: WBC ≥ 4.0×109/L, PLT ≥ 80×109/L, Hb ≥ 90g/L Renal function: Cr ≤ 2.0×UNL Hepatic function: BIL ≤ 2.0×UNL, ALT/AST ≤ 5.0×UNL Pregnant or lactating women Evidence of bleeding diathesis, serious infection Serious cardiovascular disease (congestive heart failure, uncontrollable arrhythmia, unstable angina, myocardial infarction, serious heart valve disease, resistant hypertension) Uncontrollable mental and nervous disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Endostar</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Esophageal Cancer</keyword>
</DOC>